225 related articles for article (PubMed ID: 21474540)
21. Differential sensitivity of thyroid hormone receptor isoform homodimers and mutant heterodimers to hormone-induced dissociation from deoxyribonucleic acid: its role in dominant negative action.
Zhu XG; McPhie P; Cheng SY
Endocrinology; 1997 Apr; 138(4):1456-63. PubMed ID: 9075702
[TBL] [Abstract][Full Text] [Related]
22. Defective release of corepressor by hinge mutants of the thyroid hormone receptor found in patients with resistance to thyroid hormone.
Safer JD; Cohen RN; Hollenberg AN; Wondisford FE
J Biol Chem; 1998 Nov; 273(46):30175-82. PubMed ID: 9804773
[TBL] [Abstract][Full Text] [Related]
23. Quantification of ligand-regulated nuclear receptor corepressor and coactivator binding, key interactions determining ligand potency and efficacy for the thyroid hormone receptor.
Jeyakumar M; Webb P; Baxter JD; Scanlan TS; Katzenellenbogen JA
Biochemistry; 2008 Jul; 47(28):7465-76. PubMed ID: 18558711
[TBL] [Abstract][Full Text] [Related]
24. Differential regulation of the human thyrotropin alpha-subunit promoter by thyroid hormone receptors alpha1 and beta1.
McCabe CJ; Yarwood NJ; Gurr JA; Gittoes NJ; Sheppard MC; Franklyn JA
Thyroid; 1998 Jul; 8(7):601-8. PubMed ID: 9709914
[TBL] [Abstract][Full Text] [Related]
25. Sterol regulatory element-binding protein-1 interacts with the nuclear thyroid hormone receptor to enhance acetyl-CoA carboxylase-alpha transcription in hepatocytes.
Yin L; Zhang Y; Hillgartner FB
J Biol Chem; 2002 May; 277(22):19554-65. PubMed ID: 11907029
[TBL] [Abstract][Full Text] [Related]
26. Impaired adipogenesis caused by a mutated thyroid hormone alpha1 receptor.
Ying H; Araki O; Furuya F; Kato Y; Cheng SY
Mol Cell Biol; 2007 Mar; 27(6):2359-71. PubMed ID: 17220280
[TBL] [Abstract][Full Text] [Related]
27. A novel natural mutation in the thyroid hormone receptor defines a dual functional domain that exchanges nuclear receptor corepressors and coactivators.
Tagami T; Gu WX; Peairs PT; West BL; Jameson JL
Mol Endocrinol; 1998 Dec; 12(12):1888-902. PubMed ID: 9849963
[TBL] [Abstract][Full Text] [Related]
28. Distinct dysregulation of lipid metabolism by unliganded thyroid hormone receptor isoforms.
Araki O; Ying H; Zhu XG; Willingham MC; Cheng SY
Mol Endocrinol; 2009 Mar; 23(3):308-15. PubMed ID: 19131509
[TBL] [Abstract][Full Text] [Related]
29. NCoR1-independent mechanism plays a role in the action of the unliganded thyroid hormone receptor.
Mendoza A; Astapova I; Shimizu H; Gallop MR; Al-Sowaimel L; MacGowan SMD; Bergmann T; Berg AH; Tenen DE; Jacobs C; Lyubetskaya A; Tsai L; Hollenberg AN
Proc Natl Acad Sci U S A; 2017 Oct; 114(40):E8458-E8467. PubMed ID: 28923959
[TBL] [Abstract][Full Text] [Related]
30. Differential interaction of estrogen receptor and thyroid hormone receptor isoforms on the rat oxytocin receptor promoter leads to differences in transcriptional regulation.
Vasudevan N; Davidkova G; Zhu YS; Koibuchi N; Chin WW; Pfaff D
Neuroendocrinology; 2001 Nov; 74(5):309-24. PubMed ID: 11694763
[TBL] [Abstract][Full Text] [Related]
31. Very strong correlation between dominant negative activities of mutant thyroid hormone receptors and their binding avidity for corepressor SMRT.
Matsushita A; Misawa H; Andoh S; Natsume H; Nishiyama K; Sasaki S; Nakamura H
J Endocrinol; 2000 Dec; 167(3):493-503. PubMed ID: 11115777
[TBL] [Abstract][Full Text] [Related]
32. The
Wejaphikul K; van Gucht ALM; Groeneweg S; Visser WE; Visser TJ; Peeters RP; Meima ME
Thyroid; 2019 Dec; 29(12):1834-1842. PubMed ID: 31530256
[No Abstract] [Full Text] [Related]
33. Dominant negative inhibition by mutant thyroid hormone receptors is thyroid hormone response element and receptor isoform specific.
Zavacki AM; Harney JW; Brent GA; Larsen PR
Mol Endocrinol; 1993 Oct; 7(10):1319-30. PubMed ID: 8264663
[TBL] [Abstract][Full Text] [Related]
34. Determination of nuclear receptor corepressor interactions with the thyroid hormone receptor.
Makowski A; Brzostek S; Cohen RN; Hollenberg AN
Mol Endocrinol; 2003 Feb; 17(2):273-86. PubMed ID: 12554754
[TBL] [Abstract][Full Text] [Related]
35. Thyroid hormone receptors and cancer.
Kim WG; Cheng SY
Biochim Biophys Acta; 2013 Jul; 1830(7):3928-36. PubMed ID: 22507269
[TBL] [Abstract][Full Text] [Related]
36. The thyroid axis is regulated by NCoR1 via its actions in the pituitary.
Costa-e-Sousa RH; Astapova I; Ye F; Wondisford FE; Hollenberg AN
Endocrinology; 2012 Oct; 153(10):5049-57. PubMed ID: 22878400
[TBL] [Abstract][Full Text] [Related]
37. Impaired interaction of mutant thyroid hormone receptors associated with human hepatocellular carcinoma with transcriptional coregulators.
Lin KH; Wu YH; Chen SL
Endocrinology; 2001 Feb; 142(2):653-62. PubMed ID: 11159836
[TBL] [Abstract][Full Text] [Related]
38. Pathological Interactions Between Mutant Thyroid Hormone Receptors and Corepressors and Their Modulation by a Thyroid Hormone Analogue with Therapeutic Potential.
Harrus D; Déméné H; Vasquez E; Boulahtouf A; Germain P; Figueira AC; Privalsky ML; Bourguet W; le Maire A
Thyroid; 2018 Dec; 28(12):1708-1722. PubMed ID: 30235988
[TBL] [Abstract][Full Text] [Related]
39. Thyroid hormone receptors mutated in liver cancer function as distorted antimorphs.
Chan IH; Privalsky ML
Oncogene; 2006 Jun; 25(25):3576-88. PubMed ID: 16434963
[TBL] [Abstract][Full Text] [Related]
40. An unliganded thyroid hormone beta receptor activates the cyclin D1/cyclin-dependent kinase/retinoblastoma/E2F pathway and induces pituitary tumorigenesis.
Furumoto H; Ying H; Chandramouli GV; Zhao L; Walker RL; Meltzer PS; Willingham MC; Cheng SY
Mol Cell Biol; 2005 Jan; 25(1):124-35. PubMed ID: 15601836
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
